No Prescription |
 |
 | ||
|
NORPACE Generic Disopyramide |
|
| ||
No Prescription » Prescription Drugs 12 » NORPACE Generic Disopyramide Disopyramide is used to treat abnormal heart rhythms (arrhythmias). It works by making your heart more resistant to abnormal activity.Disopyramide comes as a capsule to take by mouth. Immediate-acting disopyramide may be taken three or four times a day. The long-acting product usually is taken twice a day. Do not cut crush or chew extended-release capsules; swallow them whole.Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take disopyramide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Disopyramide helps control your condition but will not cure it. Continue to take disopyramide even if you feel well. Do not stop taking disopyramide without talking to your doctor. Buy NORPACE Generic Disopyramide and other Prescription Drugs 12 products online at Medstore. Buy Online at Medstore - Click Here!
About NORPACE Generic Disopyramide: Product Type: Prescription Drugs 12 NORPACE ( Generic Disopyramide ) NORPACE (Generic Disopyramide) Generic Disopyramide 100mg Caps Generic Disopyramide NORPACE
View more Prescription Drugs 12 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
